| Literature DB >> 25093054 |
Vahid Esfahanian1, Shirin Farhad1, Mehrnaz Sadighi Shamami2.
Abstract
Background and aims. Furcally-involved teeth present unique challenges to the success of periodontal therapy and influence treatment outcomes. This study aimed to assess to compare use of ADM and connective tissue membrane in class II furcation defect regeneration. Materials and methods. 10 patient with 2 bilaterally class II furcation defects in first and/or second maxilla or man-dibular molar without interproximal furcation involvement, were selected. Four weeks after initial phase of treatment, before and thorough the surgery pocket depth (PD), clinical attachment level to stent (CAL-S), free gingival margin to stent(FGM-S) , crestal bone to stent (Crest-S), horizontal defect depth to stent (HDD-S) and vertical defect depth to stent (VDD-S) and crestal bone to defect depth measured from stent margin. Thereafter, one side randomly treated using connective tissue and DFDBA (study group) and opposite side received ADM and DFDBA (control group). After 6 months, soft and hard tissue parameters measured again in re-entry. Results. Both groups presented improvements after therapies (P & 0.05). No inter-group differences were seen in PD re-duction (P = 0.275), CAL gain (P = 0.156), free gingival margin (P = 0.146), crest of the bone (P = 0.248), reduction in horizontal defects depth (P = 0.139) and reduction in vertical defects depth (P = 0.149). Conclusion. Both treatments modalities have potential of regeneration without any adverse effect on healing process. Connective tissue grafts did not have significant higher bone fill compared to that of ADM.Entities:
Keywords: Allograft; DFDBA; connective tissue; furcation defects; guided tissue regeneration
Year: 2014 PMID: 25093054 PMCID: PMC4120901 DOI: 10.5681/joddd.2014.018
Source DB: PubMed Journal: J Dent Res Dent Clin Dent Prospects ISSN: 2008-210X
Figure1.
Figure 2.
Figure 3. The evaluated parameters at baseline and after 6 months in the test and control groups
| Clinical parameters | Test group | Control group | P value | ||||
| Baseline | 6 Months | Changes | Baseline | 6 Months | Changes | ||
| PPD1 | 4.75±1.2 | 2.8±0.8 | 1.95 | 4.65±0.5 | 3.1±0.7 | 1.55 | 0.275 |
| CAL2 | 10.8±1.7 | 9.35±2.5 | 1.45 | 10. 9±1.9 | 10±2.4 | 0.9 | 0.156 |
| FGM-S3 | 6.05±2.1 | 6.55±1.9 | 0.5 | 6.25±2.2 | 6.9±1.3 | 0.75 | 0.146 |
| Crest-S4 | 10.65±1.5 | 11.05±1.6 | 0.6 | 10.8±1.8 | 11.15±1.2 | 0.35 | 0.148 |
| Vertical Defect Depth-S5 | 12.56±2.7 | 11.4±1.77 | 1.25 | 12.85±2.3 | 12±2.2 | 0.85 | 0.194 |
| Horizontal Defect Depth-S6 | 2.0±0.7 | 1.35±0.4 | 0.6 | 2.3±0.6 | 1.5±0.2 | 0.8 | 0.139 |
| P < 0.05 was considered statistically significant | |||||||
| 1Probing Pocket Depth (changes show depth reduction) | |||||||
| 2Clinical Attachment Level (changes show clinical attachment gain) | |||||||
| 3Free Gingival Margin to Acrylic Stent (changes show gingival recession) | |||||||
| 4Alveolar Bone Crest to Acrylic Stent (indicates crestal recession) | |||||||
| 5Vertical Defect Depth to Acrylic Stent (changes show defect fill in vertical direction) | |||||||
| 6Horizontal Defect Depth to Acrylic Stent (changes show defect fill in horizontal direction) | |||||||
Figure 4.